RxDoctor Payments Data

Kimberly Perttu, DO

Family Medicine · Lancaster, WINPI 1730314253

Payments from drug & device makers

$1,983in general payments, 2019–2025

Across 111 payments — averaging $17.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$307
  • Astellas Pharma US Inc$245
  • Pfizer$241
  • Novo Nordisk$212
  • Boehringer Ingelheim$190
  • Lilly USA, LLC$130
  • plus $658 from 15 others

What the payments were for

  • Food & beverage$1,89496%
  • Education$894%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,983 in reported general payments places this provider in the 90th percentile of 1,482 family medicine providers in Wisconsin.

See all family medicine providers in Wisconsin

Medicare billing

Part B allowed, 2024
$8,083
Medicare patients
27
Services billed
98

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
TrulicityDulaglutide49$53,042
JardianceEmpagliflozin29$35,923
EliquisApixaban34$32,534
XareltoRivaroxaban34$23,068
OzempicSemaglutide14$12,813
Advair HfaFluticasone Propion/Salmeterol12$5,095
MyrbetriqMirabegron13$4,978
Breo ElliptaFluticasone/Vilanterol12$4,804
Enoxaparin Sodium14$4,260
Fluticasone-SalmeterolFluticasone Propion/Salmeterol23$3,032
Lantus SolostarInsulin Glargine,hum.Rec.Anlog18$3,007
Metoprolol Succinate110$1,457
Ventolin HfaAlbuterol Sulfate19$1,380
Levothyroxine Sodium140$1,254
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen90$1,132

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity$130$53,04249 claims
Boehringer IngelheimJardiance$190$35,92329 claims
PfizerEliquis$241$32,53434 claims
Johnson & JohnsonXarelto$92$23,06834 claims
Novo NordiskOzempic$212$12,81314 claims
Astellas Pharma US IncMyrbetriq$245$4,97813 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,482 family medicine providers in Wisconsin.

Other family medicine in Lancaster

See the full list for Wisconsin

Where these figures come from

Is this you, or does something look wrong? →